14 April 2016

Allyson Kayton Addresses Senate Committee on the Need for Innovation in Neonatal Drug Therapies

Allyson Kayton, MSN, NNP-BC has tirelessly advocated for higher standards for neonatal care since her days working in Memorial Regional Hospital’s level II and level III neonatal intensive care units. Allyson was invited by Congress to address the Senate Committee on Health, Education, Labor and Pensions regarding S.2041 – Promoting Life-Saving New Therapies for Neonates Act of 2015.

Representing the National Association of Neonatal Nurses (NANN) and Florida Association of Neonatal Nurse Practitioners (FANNP), Allyson spoke extensively on the need to promote innovation in the development of neonatal research and drug therapy. Her testimony highlighted the existing treatment gap in neonatology and how ongoing research is necessary to address the challenges within the field. The bipartisan bill put forth by Senator Bob Casey (D-PA) and Senator Bill Cassidy (R-LA) would close the treatment gap by stimulating the development of safe, effective drugs for the neonatal population and providing incentives to drug sponsors who successfully develop products for neonates.

Thank you, Allyson, for your advocacy on behalf of our youngest, most vulnerable population. Your efforts are invaluable, not only to the field of neonatology, but to all prospective parents.